This site is intended for healthcare professionals
Drug news

Vertex update on VX 661 + Kalydeco (ivacaftor) Phase III studies for Cystic Fibrosis F508del mutation.

Read time: 1 mins
Last updated:17th Aug 2016
Published:17th Aug 2016
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest